Publication | Open Access
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE
24
Citations
41
References
2019
Year
This study demonstrated the impact of different B cell-targeted strategies on autoantibodies and IC formation and their potential clinical relevance in SLE.
| Year | Citations | |
|---|---|---|
Page 1
Page 1